Pdt Partners, LLC Halozyme Therapeutics, Inc. Transaction History

Pdt Partners, LLC

$1.58 Billion
Q2 2025

A detailed history of Pdt Partners, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 67,686 shares of HALO stock, worth $4.85 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

67,686

Previous 107,125 36.82%

Holding current value

$4.85 Million

Previous $6.84 Million 48.49%

% of portfolio

0.22%

Previous 0.54%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$47.91 - $70.14 $1.89 Million - $2.77 Million	-39,439 Reduced 36.82%	67,686 $3.52 Million
Q1 2025 May 15, 2025	BUY	$47.74 - $65.16 $1.1 Million - $1.5 Million	23,063 Added 27.44%	107,125 $6.84 Million
Q4 2024 Feb 14, 2025	BUY	$42.57 - $61.09 $2.84 Million - $4.07 Million	66,647 Added 382.7%	84,062 $4.02 Million
Q2 2024 Aug 15, 2024	SELL	$37.81 - $52.4 $1,096 - $1,519	-29 Reduced 0.17%	17,415 $911,000
Q1 2024 May 15, 2024	SELL	$33.68 - $41.95 $519,918 - $647,582	-15,437 Reduced 46.95%	17,444 $709,000
Q4 2023 Feb 14, 2024	BUY	$33.32 - $42.1 $1.1 Million - $1.38 Million	32,881 New	32,881 $1.22 Million
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $231,180 - $310,680	6,000 New	6,000 $237,000
Q1 2022 May 16, 2022	SELL	$31.97 - $41.06 $895,223 - $1.15 Million	-28,002 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $168,677 - $216,015	5,301 Added 23.35%	28,002 $1.13 Million
Q3 2021 Nov 15, 2021	BUY	$38.47 - $46.42 $873,307 - $1.05 Million	22,701 New	22,701 $923,000
Q2 2020 Aug 14, 2020	SELL	$16.25 - $26.81 $2.04 Million - $3.37 Million	-125,603 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$13.9 - $21.83 $384,599 - $604,014	27,669 Added 28.25%	125,603 $2.26 Million
Q4 2019 Feb 14, 2020	BUY	$14.93 - $19.53 $142,342 - $186,199	9,534 Added 10.79%	97,934 $1.74 Million
Q2 2019 Aug 14, 2019	SELL	$14.75 - $17.26 $457 - $535	-31 Reduced 0.04%	88,400 $1.52 Million
Q1 2019 May 15, 2019	SELL	$13.94 - $17.58 $2.13 Million - $2.68 Million	-152,449 Reduced 63.29%	88,431 $1.42 Million
Q4 2018 Feb 14, 2019	SELL	$13.33 - $18.66 $260,788 - $365,064	-19,564 Reduced 7.51%	240,880 $3.52 Million
Q3 2018 Nov 14, 2018	SELL	$16.68 - $18.41 $1.53 Million - $1.69 Million	-91,856 Reduced 26.07%	260,444 $4.73 Million
Q2 2018 Aug 14, 2018	SELL	$16.87 - $20.3 $18,371 - $22,106	-1,089 Reduced 0.31%	352,300 $5.94 Million
Q1 2018 May 15, 2018	SELL	$17.06 - $21.2 $983,167 - $1.22 Million	-57,630 Reduced 14.02%	353,389 $6.92 Million
Q4 2017 Feb 14, 2018	BUY	$16.75 - $20.8 $6.88 Million - $8.55 Million	411,019	411,019 $8.33 Million

Others Institutions Holding HALO

# of Institutions

605

Shares Held

127M

Call Options Held

408K

Put Options Held

388K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $9.99B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account